Log In
BCIQ
Print this Print this
 

Influenza alphavaccine (AVX502)

  Manage Alerts
Collapse Summary General Information
Company AlphaVax Inc.
DescriptionInfluenza vaccine containing the hemagglutinin gene from a single influenza strain
Molecular Target Not applicable
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: DNA vaccine
Latest Stage of DevelopmentPhase I/II
Standard IndicationInfluenza virus
Indication DetailsVaccinate against influenza virus
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today